ZIMMERMAN DANIEL H
Known title: Senior Vice PresidentCIK: 0001236028
Associated companies
Transaction History
| CVM | ▲ Buy | Grant | 1,266 | $4K | 9/30/2022 | View on chart |
| CVM | ▲ Buy | Grant | 876 | $4K | 6/30/2022 | View on chart |
| CVM | ▲ Buy | Grant | 1,006 | $4K | 3/31/2022 | View on chart |
| CVM | ▲ Buy | Grant | 557 | $4K | 12/31/2021 | View on chart |
| CVM | ▲ Buy | Grant | 343 | $4K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Cel-Sci stock shows high RSI and revenue divergence
Recent data for Cel-Sci Corporation indicates a high RSI reading of 85.6, suggesting the stock may be overbought. The company is also showing a six-month revenue and price divergence. Analysts maintain an average target price of $12.50, which is significantly higher than the current trading levels within the 52-week range.
Cel-Sci stock shows high RSI and revenue divergence. Recent data for Cel-Sci Corporation indicates a high RSI reading of 85.6, suggesting the stock may be overbought. The company is also showing a six-month revenue and price divergence. Analysts maintain an average target price of $12.50, which is significantly higher than the current trading levels within the 52-week range.